Collegium Pharma Cash Flow - Quarterly (NASDAQ:COLL)

Add to My Stocks
$16.95 $0.07 (0.41%) COLL stock closing price Oct 12, 2018 (Closing)

For analyzing any company like Collegium Pharma from an investment perspective, its important to check the cash flow statement. The profit-loss statement shows Collegium Pharma profits, the balance sheet shows Collegium Pharma debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. Items like capital purchases, bank loan payments etc. which have a direct impact on the cash position of a company come out through the statemement of cash flows and help an investor who undertakes the Collegium Pharma stock analysis. Collegium Pharma generated $85.26M cash from operating activities till this quarter of 2018 Q2. Collegium Pharma had an inflow of $85.26M from operating activities, $-50.45M spend due to financing activities, and $-19.86M outflow due to investing activities till 2018 Q2.

View and download details of Collegium Pharma cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q2
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow62.51M30M-------
Net Increase (Decrease) in Assets Liabilities36.74M10.05M-2.5M-2.56M-1.03M-2.63M12.71M10.37M5.25M
Cash From (used in) Discontinued Operations---------
Other Adjustments Net17.72M8.25M9.75M5.84M3.75M1.81M5.75M4.11M2.47M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.98M-0.35M-0.99M-0.81M-0.47M-0.02M-0.47M-0.13M-0.02M
Acquisition Disposition of Subsidiaires-18.87M-18.76M-------
Increase (Decrease) in Investments---------
Other Cash Inflow (Outflow) from Investment Activities-------2.5M-2.5M-2.5M
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares4.41M2.88M36.21M10.99M1.08M-138.22M51.73M51.26M
Issuance (Repayment) of Debt Securities-54.48M-3.02M-2.66M-2M-1.33M-0.66M-2.66M-2M-1.33M
Increase (Decrease) in Bank & Other Borrowings---------
Payment of Dividends & Other Cash Distributions---------
Other Cash from (used by) Financing Activities-0.38M-0.24M-0.06M-0.06M-0.13M-0.05M---
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash---------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year153.22M95.69M1.63M7.55M11.93M11.93M---
Cash & Equivalents at Year End133.74M128.95M118.69M107.61M111.2M129.55M153.22M91.02M110.74M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Collegium Pharma stock price history and Collegium Pharma stock comparison chart inevitably reflect its cash flow situation.

  • Collegium Pharma has cash of $133.74M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Collegium Pharma stock price.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. Collegium Pharma gained $85.26M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash from investing stood at a negative value of $-19.86M for COLL stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $-50.45M for Collegium Pharma. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For Collegium Pharma Cash Flow